RSS

lung cancer

Opdivo, also known as nivolumab, will now be available to NHS patients suffering from lung cancer as the drug’s manufacturer, Bristol-Myers Squibb, offers the National Institute for Health and Care Excellence (NICE) a new cancer drugs fund (CDF) deal more

News

A drug that can lead to the reduction in lung cancer tumours has been made available on the NHS. more

News

An award to progress a lung cancer candidate into the clinic has been given to Queen’s University Belfast and Domainex more

News

OSE Pharma has selected 70 international clinical centres to participate in its pivotal phase three clinical trial of Tedopi for patients diagnosed with advanced non-small cell lung cancer (NSCLC) more

News